Details
 

September 15, 2020
12:00PM - 1:00PM

MSHO Corporate Sponsor Zoom Meetings

Genentech, Global Blood Therapeutics, Incyte, Kyowa Kiran, Pharmacyclics, Puma

Zoom Meeting

Do you miss having your favorite pharma reps visit your office? MSHO will be hosting a series of Zoom lunch meetings with some of our corporate sponsors. Join your colleagues and pharma friends for 25 minutes of education and seeing each others' smiling faces!

Registration has now closed.

12:00 pm - 12:25 pm Meetings:

• Genentech
  
  • Overview: Genentech portfolio review 
• Kyowa Kiran
  
  • Overview: We have an update on Sancuso for CINV and Poteligeo for CTCL.
• Pharmacyclics
  
  • Overview: Imbruvica PI update and patient access resources

12:35 pm - 1:00 pm Meetings:

• Global Blood Therapeutics
  
  • Overview: Intervening in the Sickle Cell Disease Cascade: An Introduction to Oxbryta (Voxelator). Oxbryta is specifically designed to intervene in the Sickle Cell Disease (SCD) Cascade. The unique Mechanism of Action (MOA) directly inhibits the root cause of  sickling in SCD. Learn more to help determine which of your SCD patients may be appropriate for Oxbryta. 
• Incyte
  
  • Overview: Jakafi new data, new drug launch for Monjuvi in DLBC, new drug launch Pemazyre for iCCA, and maybe new aGVHD clinical data.
• Puma
  
  • Overview: HER2-positive Breast Cancer, Nerlynx (neratinib) updates. Now approved in both early and metastatic, dose-escalation data, NCCN Guidelines CNS breast cancer.

For questions regarding this event, please contact MSHO at 248-385-5464 or email kblazevski@msho.org.

Printer-Friendly Version